Labcorp Holdings Inc. to Present at Morgan Stanley Healthcare Conference

By Hao Liu • Friday, August 29 06:05 • Permanent Link

Labcorp Holdings, Inc. (NYSE: LH) has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, at 7:45 am ET. The company's executive management team will engage in a fireside chat during the event, with a live audio webcast available via the Company Investor Relations website at ir.Labcorp.com and archived for replay.

Labcorp, a global leader in laboratory services, employs nearly 70,000 individuals who serve clients in approximately 100 countries. In 2024, the company provided support for over 75% of the new drugs and therapeutic products approved by the FDA. Additionally, Labcorp performs more than 700 million tests annually for patients around the world. The company's comprehensive laboratory services aim to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions, ultimately advancing science to improve health and lives.

As a finance journalist, I am particularly interested in how Labcorp's key metrics have evolved since the last reporting period. This will provide valuable insight into the company's performance and potential future trajectory. Today the company's shares have moved -1.78% to a price of $274.32. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.